Detalles de la búsqueda
1.
LetibotulinumtoxinA Attenuates the Psychological Burden of Glabellar Lines and Is Associated With High Subject Satisfaction in Phase 3 Clinical Trials.
Dermatol Surg
; 50(6): 535-541, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38470985
2.
Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data.
Aesthet Surg J
; 44(4): 412-420, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37556827
3.
Safety and Duration of Effect of 40U PrabotulinumtoxinA-xvfs for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients: A Phase II, Multi-Center, Randomized, Double Blind, Active-Controlled Trial.
Aesthet Surg J
; 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38506148
4.
A Randomized, Multicenter, Evaluator-blind Study to Evaluate the Safety and Effectiveness of VYC-12L Treatment for Skin Quality Improvements.
Dermatol Surg
; 49(7): 682-688, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37163665
5.
Patient Comfort, Safety, and Effectiveness of Resilient Hyaluronic Acid Fillers Formulated With Different Local Anesthetics.
Dermatol Surg
; 48(10): 1065-1070, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36129233
6.
Efficacy and Safety of a New Resilient Hyaluronic Acid Filler in the Correction of Moderate-to-Severe Dynamic Perioral Rhytides: A 52-Week Prospective, Multicenter, Controlled, Randomized, Evaluator-Blinded Study.
Dermatol Surg
; 48(1): 87-93, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608092
7.
Injection Guidelines for Treating Midface Volume Deficiency With Hyaluronic Acid Fillers: The ATP Approach (Anatomy, Techniques, Products).
Aesthet Surg J
; 42(8): 920-934, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039828
8.
Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 3 Study.
Aesthet Surg J
; 42(6): 677-688, 2022 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092418
9.
Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L.
Dermatol Surg
; 47(1): 80-85, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33347003
10.
A Randomized, Controlled, Evaluator-Blinded, Multi-Center Study of Hyaluronic Acid Filler Effectiveness and Safety in Lip Fullness Augmentation.
Dermatol Surg
; 47(4): 527-532, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587369
11.
Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials.
Dermatol Surg
; 47(5): 649-656, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33840781
12.
AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study.
J Drugs Dermatol
; 20(9): 980-987, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34491016
13.
The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1409-1422, 2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944905
14.
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1423-1438, 2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944913
15.
DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2).
J Am Acad Dermatol
; 82(4): 838-845, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791824
16.
Efficacy and Safety of Two Resilient Hyaluronic Acid Fillers in the Treatment of Moderate-to-Severe Nasolabial Folds: A 64-Week, Prospective, Multicenter, Controlled, Randomized, Double-Blinded, and Within-Subject Study.
Dermatol Surg
; 46(12): 1521-1529, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32217842
17.
Effectiveness of a Nutraceutical During Non-Ablative 1927 nm Fractional Laser on Patients With Facial Hyperpigmentation and Photoaging.
J Drugs Dermatol
; 16(5): 501-506, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28628688
18.
Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1494, 2021 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309676
19.
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1494-1495, 2021 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34189562
20.
Efficacy and Safety of LetibotulinumtoxinA in the Treatment of Moderate and Severe Glabellar Lines in Females 35 to 50 Years of Age: Post Hoc Analyses of the Phase 3 Clinical Study Data.
Aesthet Surg J Open Forum
; 6: ojae010, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486835